Long-term follow-up in managing anaplastic astrocytoma by multimodality approach with surgery followed by postoperative radiotherapy and PCV-chemotherapy: Phase II trial

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 3, 2002, Pages 296-302

  Ron, Ilan G ^a   Gal, Ofer ^a   Vishne, Tal H ^a   Kovner, Felix ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anaplastic astrocytoma; Malignant glioma; PCV chemotherapy (procarbazine, CCNU lomustine , vincristine); Performance status; Postoperative radiotherapy

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENDER; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROSURGICAL PROCEDURES; PROCARBAZINE; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0036268996     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200206000-00020     Document Type: Article

References (36)

1. Tumours of the central nervous system
2. Brain tumors
3. Nervous system
4. Assumption in the radiotherapy of glioblastoma
5. Malignant gliomas: Tumor biology and its relation to multi modality therapy
6. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
7. Prognostic importance of tumor size in malignant gliomas: A completed tomographic scan study by the Brain Tumor Cooperative Group
8. Prognostic significance of the pretreatment CT scan on time to progression for patients with malignant gliomas
9. Effect of the extent of surgical resection on survival and quality-of-life in patients with supratentorial glioblastoma and anaplastic astrocytoma
10. Post operative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas
11. Neoplasms of the central nervous system
12. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
13. Long-term survival in patients with malignant astrocytoma
14. Meta analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
15. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment for malignant glioma. Brain Tumor Cooperative Group Trial 8001
16. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV), over BCNU for anaplastic gliomas: NCOG 6G61 final report
17. Advantage of post radiotherapy chemotherapy with PCV over chemotherapy with VM-26 and CCNU for malignant gliomas
18. Non parametric estimation from incomplete observation
19. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas
20. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumour and its influence on regrowth and prognosis
21. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials
22. Highly anaplastic astrocytoma: A review of 357 patients treated between 1977 and 1989
23. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials
24. Long-term survival in treated anaplastic astrocytomas: A report of combined RTOG/ECOG studies
25. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme
26. Stereotactic radiosurgery for glioblastoma multiforme: Report of prospective study evaluating prognostic factors and analyzing long-term survival advantage
27. Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome
28. Radiation therapy for neoplasms of the brain
29. Malignant glioma: Who benefits from adjuvant chemotherapy?
30. Long term survival in malignant gliomas. Prognostic factors
31. Long term follow up results with malignant gliomas
32. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of Radiation Therapy Oncology Group 82-02
33. Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group
34. Chemotherapeutic approaches to the treatment of malignant gliomas